Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This is a comparator study to assess safety and efficacy of Flutiform compared with
Fluticasone pMDI and Seretide pMDI in paediatric asthma patients with moderate to severe
persistent, reversible asthma.
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma Research Limited
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination